JFG
JAZZ icon

Jefferies Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Jefferies Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.2M Buy
175,599
+172,099
+4,917% +$30.1M 0.23% 75
2025
Q4 		$595K Buy
+3,500
New +$537K ﹤0.01% 1278
2025
Q2 		– Sell
-11,213
Closed -$1.39M – 1569
2025
Q1 		$1.39M Buy
+11,213
New +$1.46M 0.01% 683
2024
Q2 		– Sell
-46,662
Closed -$5.62M – 1630
2024
Q1 		$5.62M Sell
46,662
-3,815
-8% -$467K 0.05% 287
2023
Q4 		$6.21M Buy
50,477
+48,001
+1,939% +$5.99M 0.04% 336
2023
Q3 		$320K Buy
+2,476
New +$330K ﹤0.01% 1211

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jefferies Financial Group's JAZZ Position: Q1 2026 in Review

Jefferies Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 4,917% in Q1 2026, buying an estimated $30.1M and bringing the position to 175,599 shares worth $33.2M. The position accounts for 0.23% of the portfolio, ranked #75.

Jefferies Financial Group first reported a position in JAZZ in Q3 2023 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Jefferies Financial Group held 175,599 shares of Jazz Pharmaceuticals worth $33.2M as of Q1 2026.
  • Jefferies Financial Group bought 172,099 Jazz Pharmaceuticals shares in Q1 2026, an estimated $30.1M.
  • Jazz Pharmaceuticals made up 0.23% of Jefferies Financial Group's portfolio in Q1 2026, its #75 holding.
  • Jefferies Financial Group first reported a position in Jazz Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.